High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|20|3|654-659

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.20, Iss.3, 2018-03, pp. : 654-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Risk Assessment Using High-Sensitivity C-Reactive Protein in Patients with Erectile Dysfunction

By  

Urologia Internationalis, Vol. 91, Iss. 2, 2013-06 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Association of total cholesterol, low‐density lipoprotein cholesterol, and non‐high‐density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1209-1217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular Outcomes Trials in Type 2 Diabetes Mellitus

By  

Cardiology, Vol. 135, Iss. 2, 2016-06 ,pp. : 108-126

Karger

Access to resources Recommend Favorite

Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 20-22

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 628-635

John Wiley & Sons Inc

Access to resources Recommend Favorite